½ÅÃ̼¼ºê¶õ½ºº´¿ø Á¦19ȸ Çѱ¹Æ÷µµ¸·ÇÐȸ ½ÉÆ÷Áö¾ö : 2019-11-10±³À°ÀÏÀÚ : 2019-11-10
±³À°Àå¼Ò : ½ÅÃ̼¼ºê¶õ½ºº´¿ø º»°ü6Ãþ Àº¸í´ë°´ç
±³À°ÁÖÁ¦ :
Á¦19ȸ Çѱ¹Æ÷µµ¸·ÇÐȸ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹Æ÷µµ¸·ÇÐȸ
´ã´çÀÚ : À̹̿¬
¿¬¶ôó : 02-3410-3568
À̸ÞÀÏ :
miyeon93@samsung.com ±³À°Á¾·ù : ¾È°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ï: Àü°øÀÇ-40,000¿ø, Àü¹®ÀÇ-60,000¿ø ÇöÀåµî·Ï: Àü°øÀÇ-60,000¿ø, Àü¹®ÀÇ-80,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-10 09:00~09:10 Changing trends in epidemiology ÀÌÁÖ¿ë(¿ï»ê´ë)
±³À°½Ã°£ 11-10 09:10~09:20 Changing diagnostic criteria ¹®»ó¿õ(°æÈñ´ë)
±³À°½Ã°£ 11-10 09:20~09:30 Changing guidelines for treatment ±è¼±¿ì(°í·Á´ë)
±³À°½Ã°£ 11-10 09:30~09:40 Review of clinical trials À¯½Â¿µ(°æÈñ´ë)
±³À°½Ã°£ 11-10 09:40~09:50 Insurance and cost-effectiveness of current treatment options ¿ÀÀç·É(°í·Á´ë)
±³À°½Ã°£ 11-10 09:50~10:00 Unmet needs and unanswered questions ±èÇö¿õ(ÀÎÁ¦´ë)
±³À°½Ã°£ 11-10 11:15~11:40 ³»°¡ º» ¿ì¸®³ª¶ó Æ÷µµ¸·Áúȯ Áø·áÀÇ ¹ßÀü»ç Á¤Èì(Áß¾Ó´ë)
±³À°½Ã°£ 11-10 11:40~12:05 ³»°¡ °æÇèÇÑ ÁÖº¯ºÎ ¸Á¸·Æ÷µµ¸· º´º¯µé À̼ºÃ¶(¿¬¼¼´ë)
±³À°½Ã°£ 11-10 12:05~12:15 »çÁøÀ¸·Î º¸´Â Æ÷µµ¸·ÇÐȸ 10³â»ç ÇÔµ·ÀÏ(¼º±Õ°ü´ë)
±³À°½Ã°£ 11-10 13:20~13:30 Episcleritis, scleritis, and keratouveitis ±è¹Ì±Ý(¼¿ï´ë)
±³À°½Ã°£ 11-10 13:30~13:40 Tips and pearls in history taking and basic ophthalmic examination »ç°ø¹Î(¿µ³²´ë)
±³À°½Ã°£ 11-10 13:40~13:50 Tips and pearls in diagnosing process À̽±Ô(¿¬¼¼´ë)
±³À°½Ã°£ 11-10 13:50~14:00 Tips and pearls in medical management ÀÌÁ¾Çö(ÀÎÁ¦´ë)
±³À°½Ã°£ 11-10 14:00~14:10 Tips and pearls in periocular and intravitreal injection ÃÖ°æ½Ä(¼øõÇâ´ë)
±³À°½Ã°£ 11-10 14:10~14:20 Tips and pearls in surgical management Á¶¿µÁØ(Ãæ³²´ë)
±³À°½Ã°£ 11-10 14:20~14:30 Tips and pearls in managing pediatric uveitis ±è»óÁø(¼º±Õ°ü´ë)
±³À°½Ã°£ 11-10 14:50~15:10 Case study 1 & Discussion ¹Ú¼ºÈÄ(ºÎ»ê´ë)
±³À°½Ã°£ 11-10 15:10~15:30 Case study 2 & Discussion Á¶¹üÁÖ(ÇѸ²´ë)
±³À°½Ã°£ 11-10 15:30~15:50 Case study 3 & Discussion °ø¹Î±Í(°¡Å縯 °üµ¿´ë)
±³À°½Ã°£ 11-10 15:50~16:10 Case study 4 & Discussion ÀÌ°æ¹Î(°¡Å縯 °üµ¿´ë)
±³À°½Ã°£ 11-10 16:10~16:30 Case study 5 & Discussion ½ÅÁÖ¿µ(¼¿ï´ë)
±³À°½Ã°£ 11-10 16:30~16:50 Case study 6 & Discussion ¾È¼ºÁØ(ÇѾç´ë)